Douglas Kerr - 15 Jul 2022 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jennifer Elliott, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
15 Jul 2022
Transactions value $
-$31,355
Form type
4
Filing time
19 Jul 2022, 16:19:45 UTC
Previous filing
25 Jan 2022
Next filing
18 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +14.9K +4.52% 344K 15 Jul 2022 Direct F1, F2
transaction GBIO Common Stock Tax liability -$31.4K -4.37K -1.27% $7.18 340K 15 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -14.9K -25% $0.00 44.6K 15 Jul 2022 Common Stock 14.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the company's common stock.
F2 Includes 2,480 shares acquired under the company's employee stock purchase plan since July 8, 2021.
F3 On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.